Clinical implications of cytogenetic heterogeneity in multiple myeloma patients with TP53 deletion.
Hao S, Lin P, Medeiros LJ, Fang L, Carballo-Zarate AA, Konoplev SN, Sargent RL, Weber DM, Thomas SK, Manasanch EE, Orlowski RZ, Lu X.
Hao S, et al. Among authors: sargent rl.
Mod Pathol. 2017 Oct;30(10):1378-1386. doi: 10.1038/modpathol.2017.63. Epub 2017 Jun 30.
Mod Pathol. 2017.
PMID: 28664940
Free PMC article.